B., Crawford, T
Its really showing the cardiovascular community that in addition to what weve learned about the protection, particularly from atherosclerotic events, with GLP-1s, theres also profound kidney protection and it affects survival, Katherine R
There are currently no FDA-approved drug therapies for MASH, and the disease is characterized by excess fat accumulation and inflammation in the liver, which leads to liver scarring or fibrosis
I read scripts for those kinds of things
When your body breaks down protein, it produces nitrogen waste
Obesity is often associated with a myriad of health complications, including cardiovascular disease, hypertension, and even certain types of cancer